US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 45.610
  • +2.570+5.97%
Close Apr 30 16:00 ET
  • 45.610
  • 0.0000.00%
Post 20:01 ET
3.63BMarket Cap-12.16P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
35.10%743.08M
35.10%743.08M
29.30%717.25M
18.88%760.19M
163.29%903.67M
56.50%550.01M
56.50%550.01M
48.32%554.73M
253.82%639.44M
107.54%343.22M
-Cash and cash equivalents
45.27%340.24M
45.27%340.24M
17.26%316.07M
-30.12%310.36M
141.91%623.85M
-6.23%234.21M
-6.23%234.21M
-27.93%269.55M
149.91%444.16M
71.36%257.88M
-Short-term investments
27.56%402.84M
27.56%402.84M
40.67%401.18M
130.35%449.84M
227.89%279.81M
210.60%315.8M
210.60%315.8M
--285.19M
6,413.94%195.29M
473.24%85.34M
Other current assets
174.34%27.3M
174.34%27.3M
39.51%29.64M
320.75%15.82M
78.46%7.62M
167.24%9.95M
167.24%9.95M
438.85%21.25M
9.85%3.76M
66.81%4.27M
Total current assets
37.58%770.38M
37.58%770.38M
29.67%746.89M
20.65%776.01M
162.25%911.28M
57.66%559.96M
57.66%559.96M
52.40%575.98M
249.29%643.2M
106.92%347.49M
Non current assets
Net PPE
-26.41%755K
-26.41%755K
-23.25%835K
-21.88%900K
-21.13%963K
-20.40%1.03M
-20.40%1.03M
-19.65%1.09M
-18.87%1.15M
-17.78%1.22M
-Gross PPE
-26.41%755K
-26.41%755K
-23.25%835K
-21.88%900K
-21.13%963K
-20.40%1.03M
-20.40%1.03M
-19.65%1.09M
-18.87%1.15M
-17.78%1.22M
Investments and advances
183.93%54.75M
183.93%54.75M
19.84%69.82M
353.10%88.13M
--0
--19.28M
--19.28M
--58.26M
--19.45M
----
Other non current assets
----
----
----
----
----
----
----
----
----
-76.92%108K
Total non current assets
173.31%55.51M
173.31%55.51M
19.05%70.66M
332.14%89.03M
-27.54%963K
1,353.76%20.31M
1,353.76%20.31M
3,959.64%59.35M
1,248.36%20.6M
-31.95%1.33M
Total assets
42.33%825.89M
42.33%825.89M
28.68%817.55M
30.32%865.04M
161.52%912.24M
62.74%580.27M
62.74%580.27M
67.45%635.33M
257.51%663.81M
105.32%348.82M
Liabilities
Current liabilities
Payables
28.26%9.03M
28.26%9.03M
120.21%25.22M
43.94%14.57M
94.68%13.78M
-11.67%7.04M
-11.67%7.04M
90.58%11.45M
47.17%10.12M
59.10%7.08M
-accounts payable
28.26%9.03M
28.26%9.03M
120.21%25.22M
43.94%14.57M
94.68%13.78M
-11.67%7.04M
-11.67%7.04M
90.58%11.45M
47.17%10.12M
59.10%7.08M
Current accrued expenses
181.59%28.93M
181.59%28.93M
18.71%13.07M
49.21%12.86M
82.72%13.61M
2.86%10.27M
2.86%10.27M
-32.69%11.01M
-51.20%8.62M
-53.41%7.45M
Current debt and capital lease obligation
20.88%631K
20.88%631K
-75.55%631K
27.59%629K
56.10%640K
60.62%522K
60.62%522K
751.82%2.58M
93.33%493K
93.40%410K
-Current debt
----
----
----
----
----
----
----
--2.08M
----
----
-Current capital lease obligation
20.88%631K
20.88%631K
24.95%631K
27.59%629K
56.10%640K
60.62%522K
60.62%522K
66.67%505K
93.33%493K
93.40%410K
Current liabilities
107.83%39.75M
107.83%39.75M
52.18%43.29M
44.31%31.17M
81.43%30.26M
0.24%19.13M
0.24%19.13M
12.69%28.45M
-19.08%21.6M
-24.52%16.68M
Non current liabilities
Long term debt and capital lease obligation
38.95%35.83M
38.95%35.83M
51.03%35.73M
38.77%35.64M
38.70%35.55M
142.78%25.78M
142.78%25.78M
123.44%23.66M
143.09%25.68M
1,942.47%25.63M
-Long term debt
41.39%35.3M
41.39%35.3M
54.26%35.12M
41.37%34.96M
41.38%34.8M
161.65%24.96M
161.65%24.96M
141.01%22.77M
164.02%24.73M
--24.62M
-Long term capital lease obligation
-35.41%529K
-35.41%529K
-31.87%605K
-28.83%679K
-26.25%750K
-24.10%819K
-24.10%819K
-22.11%888K
-20.43%954K
-18.96%1.02M
Derivative product liabilities
----
----
--203K
----
----
----
----
----
----
----
Other non current liabilities
259.26%194K
259.26%194K
----
92.94%164K
9.88%178K
-82.30%54K
-82.30%54K
32.86%93K
107.32%85K
--162K
Total non current liabilities
39.41%36.02M
39.41%36.02M
51.29%35.93M
38.95%35.8M
38.52%35.73M
136.49%25.84M
136.49%25.84M
122.85%23.75M
142.95%25.77M
1,955.38%25.8M
Total liabilities
68.52%75.77M
68.52%75.77M
51.78%79.22M
41.39%66.98M
55.37%65.99M
49.84%44.97M
49.84%44.97M
45.39%52.2M
26.98%47.37M
81.88%42.47M
Shareholders'equity
Share capital
16.67%7K
16.67%7K
16.67%7K
16.67%7K
40.00%7K
20.00%6K
20.00%6K
20.00%6K
50.00%6K
25.00%5K
-common stock
16.67%7K
16.67%7K
16.67%7K
16.67%7K
40.00%7K
20.00%6K
20.00%6K
20.00%6K
50.00%6K
25.00%5K
Retained earnings
-43.91%-826.16M
-43.91%-826.16M
-45.72%-756.13M
-42.60%-683.43M
-40.00%-627.44M
-35.93%-574.1M
-35.93%-574.1M
-29.96%-518.91M
-31.76%-479.25M
-33.25%-448.17M
Paid-in capital
42.03%1.58B
42.03%1.58B
35.35%1.49B
35.20%1.48B
95.33%1.47B
48.11%1.11B
48.11%1.11B
48.43%1.1B
114.00%1.1B
56.24%754.49M
Gains losses not affecting retained earnings
251.11%948K
251.11%948K
515.61%2.1M
-3.98%-261K
-476.19%-79K
629.73%270K
629.73%270K
---506K
-8,266.67%-251K
170.00%21K
Total stockholders'equity
40.13%750.11M
40.13%750.11M
26.61%738.33M
29.46%798.07M
176.24%846.25M
63.92%535.31M
63.92%535.31M
69.76%583.14M
315.47%616.44M
109.06%306.35M
Total equity
40.13%750.11M
40.13%750.11M
26.61%738.33M
29.46%798.07M
176.24%846.25M
63.92%535.31M
63.92%535.31M
69.76%583.14M
315.47%616.44M
109.06%306.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 35.10%743.08M35.10%743.08M29.30%717.25M18.88%760.19M163.29%903.67M56.50%550.01M56.50%550.01M48.32%554.73M253.82%639.44M107.54%343.22M
-Cash and cash equivalents 45.27%340.24M45.27%340.24M17.26%316.07M-30.12%310.36M141.91%623.85M-6.23%234.21M-6.23%234.21M-27.93%269.55M149.91%444.16M71.36%257.88M
-Short-term investments 27.56%402.84M27.56%402.84M40.67%401.18M130.35%449.84M227.89%279.81M210.60%315.8M210.60%315.8M--285.19M6,413.94%195.29M473.24%85.34M
Other current assets 174.34%27.3M174.34%27.3M39.51%29.64M320.75%15.82M78.46%7.62M167.24%9.95M167.24%9.95M438.85%21.25M9.85%3.76M66.81%4.27M
Total current assets 37.58%770.38M37.58%770.38M29.67%746.89M20.65%776.01M162.25%911.28M57.66%559.96M57.66%559.96M52.40%575.98M249.29%643.2M106.92%347.49M
Non current assets
Net PPE -26.41%755K-26.41%755K-23.25%835K-21.88%900K-21.13%963K-20.40%1.03M-20.40%1.03M-19.65%1.09M-18.87%1.15M-17.78%1.22M
-Gross PPE -26.41%755K-26.41%755K-23.25%835K-21.88%900K-21.13%963K-20.40%1.03M-20.40%1.03M-19.65%1.09M-18.87%1.15M-17.78%1.22M
Investments and advances 183.93%54.75M183.93%54.75M19.84%69.82M353.10%88.13M--0--19.28M--19.28M--58.26M--19.45M----
Other non current assets -------------------------------------76.92%108K
Total non current assets 173.31%55.51M173.31%55.51M19.05%70.66M332.14%89.03M-27.54%963K1,353.76%20.31M1,353.76%20.31M3,959.64%59.35M1,248.36%20.6M-31.95%1.33M
Total assets 42.33%825.89M42.33%825.89M28.68%817.55M30.32%865.04M161.52%912.24M62.74%580.27M62.74%580.27M67.45%635.33M257.51%663.81M105.32%348.82M
Liabilities
Current liabilities
Payables 28.26%9.03M28.26%9.03M120.21%25.22M43.94%14.57M94.68%13.78M-11.67%7.04M-11.67%7.04M90.58%11.45M47.17%10.12M59.10%7.08M
-accounts payable 28.26%9.03M28.26%9.03M120.21%25.22M43.94%14.57M94.68%13.78M-11.67%7.04M-11.67%7.04M90.58%11.45M47.17%10.12M59.10%7.08M
Current accrued expenses 181.59%28.93M181.59%28.93M18.71%13.07M49.21%12.86M82.72%13.61M2.86%10.27M2.86%10.27M-32.69%11.01M-51.20%8.62M-53.41%7.45M
Current debt and capital lease obligation 20.88%631K20.88%631K-75.55%631K27.59%629K56.10%640K60.62%522K60.62%522K751.82%2.58M93.33%493K93.40%410K
-Current debt ------------------------------2.08M--------
-Current capital lease obligation 20.88%631K20.88%631K24.95%631K27.59%629K56.10%640K60.62%522K60.62%522K66.67%505K93.33%493K93.40%410K
Current liabilities 107.83%39.75M107.83%39.75M52.18%43.29M44.31%31.17M81.43%30.26M0.24%19.13M0.24%19.13M12.69%28.45M-19.08%21.6M-24.52%16.68M
Non current liabilities
Long term debt and capital lease obligation 38.95%35.83M38.95%35.83M51.03%35.73M38.77%35.64M38.70%35.55M142.78%25.78M142.78%25.78M123.44%23.66M143.09%25.68M1,942.47%25.63M
-Long term debt 41.39%35.3M41.39%35.3M54.26%35.12M41.37%34.96M41.38%34.8M161.65%24.96M161.65%24.96M141.01%22.77M164.02%24.73M--24.62M
-Long term capital lease obligation -35.41%529K-35.41%529K-31.87%605K-28.83%679K-26.25%750K-24.10%819K-24.10%819K-22.11%888K-20.43%954K-18.96%1.02M
Derivative product liabilities ----------203K----------------------------
Other non current liabilities 259.26%194K259.26%194K----92.94%164K9.88%178K-82.30%54K-82.30%54K32.86%93K107.32%85K--162K
Total non current liabilities 39.41%36.02M39.41%36.02M51.29%35.93M38.95%35.8M38.52%35.73M136.49%25.84M136.49%25.84M122.85%23.75M142.95%25.77M1,955.38%25.8M
Total liabilities 68.52%75.77M68.52%75.77M51.78%79.22M41.39%66.98M55.37%65.99M49.84%44.97M49.84%44.97M45.39%52.2M26.98%47.37M81.88%42.47M
Shareholders'equity
Share capital 16.67%7K16.67%7K16.67%7K16.67%7K40.00%7K20.00%6K20.00%6K20.00%6K50.00%6K25.00%5K
-common stock 16.67%7K16.67%7K16.67%7K16.67%7K40.00%7K20.00%6K20.00%6K20.00%6K50.00%6K25.00%5K
Retained earnings -43.91%-826.16M-43.91%-826.16M-45.72%-756.13M-42.60%-683.43M-40.00%-627.44M-35.93%-574.1M-35.93%-574.1M-29.96%-518.91M-31.76%-479.25M-33.25%-448.17M
Paid-in capital 42.03%1.58B42.03%1.58B35.35%1.49B35.20%1.48B95.33%1.47B48.11%1.11B48.11%1.11B48.43%1.1B114.00%1.1B56.24%754.49M
Gains losses not affecting retained earnings 251.11%948K251.11%948K515.61%2.1M-3.98%-261K-476.19%-79K629.73%270K629.73%270K---506K-8,266.67%-251K170.00%21K
Total stockholders'equity 40.13%750.11M40.13%750.11M26.61%738.33M29.46%798.07M176.24%846.25M63.92%535.31M63.92%535.31M69.76%583.14M315.47%616.44M109.06%306.35M
Total equity 40.13%750.11M40.13%750.11M26.61%738.33M29.46%798.07M176.24%846.25M63.92%535.31M63.92%535.31M69.76%583.14M315.47%616.44M109.06%306.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
eBay
EBAY
68.160
Halozyme Therapeutics
HALO
61.420
Constellation Brands
STZ
187.540
4
Workday
WDAY
245.000
5
Lantheus
LNTH
104.340
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀